Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis

BACKGROUND: Whether a combination of chemotherapy and erlotinib is beneficial for advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to summarize the currently available evidence and compare the efficacy and safety of chemotherapy plus erlotinib versus chemotherapy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, J. L., Jin, B., Ren, Z. H., Lou, Y. Q., Zhou, Z. R., Yang, Q. Z., Han, B. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493135/
https://www.ncbi.nlm.nih.gov/pubmed/26147288
http://dx.doi.org/10.1371/journal.pone.0131278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493135/
https://www.ncbi.nlm.nih.gov/pubmed/26147288
http://dx.doi.org/10.1371/journal.pone.0131278

Ejemplares similares